Aileron Therapeutics, Inc.(ALRN) a Boston-based biopharmaceutical company Friday has announced that it has rebranded itself into Rein Therapeutics, Inc. The updated name, logo, website, and branding represent the Company's mission to create breakthrough treatments to combat diseases.
ALRN's stock will start to trade under the Nasdaq ticker "RNTX" from January 13, 2025. The CUSIP number for the company's common stock remains unchanged.
Currently, is trading at $2.01 or 4.1451% higher on the Nasdaq Capital Market.
For comments and feedback contact: editorial@rttnews.com
Business News
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.